梅斯医学网站增加“话题”功能,随时拥有属于自己的话题

2020-06-05 MedSci MedSci原创

为了更好方便大家交流,此次随着网站升级,特别增加了“话题”功能。

为了更好方便大家交流,此次随着网站升级,特别增加了“话题”功能。

只要您在任何地方参与互动或评论,用##将您关注的词间隔出来,就自动形成话题。甚至您还可以用您的名字形成话题哦。当然,更多地关注您的研究方向,疾病,药物作为话题更好。

通过话题,您能与更多的同好进行交流,还能通过话题获取最新的信息,不同人的观点。

如果您是第一个发起话题的,就能自动成为话题发起人。

目前话题在梅斯医学APP端,很方便参与,通过APP,可以进行语音录入,速度很快。不过随后将开放电脑端的参与互动。

如果对话题功能感兴趣,可以参与#话题#讨论

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=807046, encodeId=dac080e04641, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> 好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200808/ff5bb6811bcd4e22bab702afc6e1ab9b/9b2e5c89d2034a77a1a71a0e2ab31825.jpg, createdBy=46785409691, createdName=「 D°」, createdTime=Sun Aug 09 07:34:16 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277117, encodeId=bd8912e7117fd, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 07 01:33:13 CST 2020, time=2020-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601511, encodeId=957e601511e4, content=试试<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:31 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601510, encodeId=539860151028, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:01 CST 2020, time=2020-06-05, status=1, ipAttribution=)]
    2020-08-09 「 D°」
  2. [GetPortalCommentsPageByObjectIdResponse(id=807046, encodeId=dac080e04641, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> 好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200808/ff5bb6811bcd4e22bab702afc6e1ab9b/9b2e5c89d2034a77a1a71a0e2ab31825.jpg, createdBy=46785409691, createdName=「 D°」, createdTime=Sun Aug 09 07:34:16 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277117, encodeId=bd8912e7117fd, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 07 01:33:13 CST 2020, time=2020-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601511, encodeId=957e601511e4, content=试试<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:31 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601510, encodeId=539860151028, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:01 CST 2020, time=2020-06-05, status=1, ipAttribution=)]
    2020-06-07 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=807046, encodeId=dac080e04641, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> 好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200808/ff5bb6811bcd4e22bab702afc6e1ab9b/9b2e5c89d2034a77a1a71a0e2ab31825.jpg, createdBy=46785409691, createdName=「 D°」, createdTime=Sun Aug 09 07:34:16 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277117, encodeId=bd8912e7117fd, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 07 01:33:13 CST 2020, time=2020-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601511, encodeId=957e601511e4, content=试试<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:31 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601510, encodeId=539860151028, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:01 CST 2020, time=2020-06-05, status=1, ipAttribution=)]
    2020-06-05 lifefamily@163

    试试#话题#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=807046, encodeId=dac080e04641, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> 好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200808/ff5bb6811bcd4e22bab702afc6e1ab9b/9b2e5c89d2034a77a1a71a0e2ab31825.jpg, createdBy=46785409691, createdName=「 D°」, createdTime=Sun Aug 09 07:34:16 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277117, encodeId=bd8912e7117fd, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 07 01:33:13 CST 2020, time=2020-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601511, encodeId=957e601511e4, content=试试<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:31 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601510, encodeId=539860151028, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily@163, createdTime=Fri Jun 05 18:33:01 CST 2020, time=2020-06-05, status=1, ipAttribution=)]
    2020-06-05 lifefamily@163

    好用

    0

相关资讯

2019年两会预测:医药领域9大热门话题

“医药”是三医联动的三大要素之一,不仅代表着国家医药产业的发展水平,更是与广大人民群众福祉息息相关。在刚刚过去的2018年,医药领域接连发生了数件大事,无论是足以推动行业发展的重大利好政策,还是导致医药股集体跳水的“黑天鹅事件”,都让原本就风起云涌的行业格局更加变幻莫测,也让2019年的“医药”更值得我们期待。在2019年两会前夕,小保通过搜集资料以及听取多位业内人士的发言,预测了今年医药领域